Group 1 - The core point of the article highlights the performance and holdings of the Fuqua Precision Medical Mixed A fund, which has shown significant returns over various time frames [1] - As of June 20, 2025, the latest net value of the fund is 3.0382 yuan, reflecting a decrease of 0.86% [1] - The fund's one-month return is 7.22%, ranking 29 out of 1536 in its category; the six-month return is 32.59%, ranking 7 out of 1518; and the year-to-date return is 36.35%, ranking 8 out of 1519 [1] Group 2 - The top ten stock holdings of the Fuqua Precision Medical Mixed A fund account for a total of 69.71%, with significant positions in companies such as Baile Tianheng (9.66%), Haizike (9.65%), and Kelun Pharmaceutical (9.10%) [1] - The fund was established on November 16, 2017, and as of March 31, 2025, it has a total scale of 3.746 billion yuan [1] - The fund manager, Zhao Wei, has extensive experience in the pharmaceutical and investment sectors, having held various positions in notable companies before joining Fuqua [2]
6月20日富国精准医疗混合A净值下跌0.86%，近1个月累计上涨7.22%
Sou Hu Cai Jing·2025-06-20 12:39